Intralytix, Inc. is a privately owned biotech venture incorporated in the State of Maryland on July 28, 1998. Intralytix specializes in bacteriophage based products used to control bacterial pathogens in environmental, agricultural, food processing, and medical settings. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intralytix (United States), United States, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
73%
Total
Publications
74
Total Open
Publications
54
Total
Citations
4.6K
Open Access
Percentage
73%
Total
Publications
74
Total Open
Publications
54
Total
Citations
4.6K
Breakdown
Publisher Open
30%
Both
35%
Other Platform Open
6%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 58%
26
Hybrid 11%
5
No Guarantees 31%
14
Other Platform Open
Domain 77%
24
Institution 29%
9
Other Internet 23%
7
Public 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 24 |
DOI | Other Internet | 7 |
VU Research Portal | Institution | 2 |
DANS - Data Archiving and Networked Services | Institution | 2 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |
Spanish National Research Council (CSIC - DIGITAL.CSIC) | Institution | 1 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 1 |
KU Leuven - Lirias | Institution | 1 |
Figshare | Public | 1 |
Europe PMC | Domain | 1 |